Detalhe da pesquisa
1.
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10403): 705-719, 2023 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385278
2.
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet
; 402(10402): 613-626, 2023 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385275
3.
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis.
Diabetes Obes Metab
; 26(1): 319-328, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932236
4.
Correction: Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
PLoS Med
; 20(3): e1004217, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996411
5.
Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial.
Diabetes Obes Metab
; 25(12): 3748-3756, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700443
6.
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses.
Diabetes Obes Metab
; 25(2): 468-478, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200477
7.
American Association of Clinical Endocrinology Consensus Statement: Addressing Stigma and Bias in the Diagnosis and Management of Patients with Obesity/Adiposity-Based Chronic Disease and Assessing Bias and Stigmatization as Determinants of Disease Severity.
Endocr Pract
; 29(6): 417-427, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140524
8.
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes.
Pediatr Exerc Sci
; 35(3): 165-173, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543176
9.
Examining the evidence for weight management in individuals with type 2 diabetes.
Diabetes Obes Metab
; 24(8): 1411-1422, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545861
10.
Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications.
Endocr Pract
; 28(2): 214-222, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823000
11.
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD).
Endocr Pract
; 28(5): 528-562, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35569886
12.
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.
Endocr Pract
; 28(10): 923-1049, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963508
13.
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
JAMA
; 327(2): 138-150, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015037
14.
Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women.
Am J Physiol Endocrinol Metab
; 320(5): E864-E873, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33645254
15.
Genetic landscape of Gullah African Americans.
Am J Phys Anthropol
; 175(4): 905-919, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34008864
16.
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
JAMA
; 325(14): 1403-1413, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625476
17.
Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
PLoS Med
; 17(8): e1003232, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32764746
18.
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes.
Int J Obes (Lond)
; 44(5): 990-998, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949295
19.
Covid-19 & Obesity: Beyond Bmi.
Endocr Pract
; 26(8): 923-925, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471684
20.
Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.
J Lipid Res
; 60(8): 1432-1439, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31203233